Clinical Characteristics Predict Benefits From Eptifibatide Therapy During Coronary Stenting
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference11 articles.
1. The pathogenesis of coronary artery disease and the acute coronary syndromes;Fuster;N Engl J Med,1992
2. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty;N Engl J Med,1994
3. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization;N Engl J Med,1997
4. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina;Lancet,1997
5. Randomized placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis-II;Lancet,1997
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of Parenteral Agents in PCI for Stable Patients;Interventional Cardiology;2016-11-19
2. Cardiovascular Pharmacogenetics of Anti-Thrombotic Agents and Non-Steroidal Anti-Inflammatory Drugs;Current Molecular Medicine;2014-08-11
3. Clinical and economic studies of eptifibatide in coronary stenting;Therapeutics and Clinical Risk Management;2014-08
4. Role of Parenteral Agents in Percutaneous Coronary Intervention for Stable Patients;Interventional Cardiology Clinics;2013-10
5. Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany;The European Journal of Health Economics;2011-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3